Complex natural products usually adopt precisely defined spatial structures that are of critical importance to their biological function. A substrate must fit precisely into the “pocket” of an enzyme in order to be converted. The same is true of drugs meant to influence the function of enzymes. The biggest challenge in this is to develop effective methods for the synthesis of agents with tailored three-dimensional structures.
A team of British and American researchers headed by Eric Meggers is using metal atoms to give their agents the right shape. They have now successfully used this concept to develop a specific inhibitor for protein kinase Pim-1 based on a ruthenium complex.
Protein kinases play an important role in a large number of cellular regulatory mechanisms. The natural compound staurosporine is an effective inhibitor for the adenosine triphosphate (ATP) dependent protein kinases because it fits precisely into the ATP-binding cavity of these enzymes. Meggers and his team at the University of Pennsylvania (USA) and Oxford University (UK) used the structure of staurosporine as the starting point for the development of a more simply constructed metal-containing inhibitor. Staurosporine consists of a flat aromatic ring system and a sugar component. The scientists replaced the sugar with a ruthenium atom bound to two ligands. The ring system, which was slightly altered, also binds to the ruthenium as a ligand. Like a clamp, it surrounds the metal from two sides. Careful selection of the two other ligands—carbon monoxide and an five-membered aromatic ring—allowed the researchers to give their ruthenium complex a form that mimics the spatial structure of staurosporine and also fits into the ATP-binding cavity.
The new ruthenium complex exists in two forms that are mirror images of each other. Tests with more than 50 different kinases showed that the “left-hand” version very specifically inhibits an enzyme called Pim-1 kinase—more than two orders of magnitude more effectively than staurosporine. Pim-1 kinase participates in the regulation of cell division: its inhibition could be advantageous in fighting certain tumors.
“The metal in such complexes is tightly bound so that it cannot be easily released and is supposed to be nontoxic,” stresses Meggers. “Its only job is to hold the individual ligands in the right spatial arrangement. In comparison to the purely organic compounds on which their structure is based, organometallic complexes are more simply constructed and are correspondingly easier to synthesize.”
Source: Angewandte Chemie
Related stories:
Scientists use old enemy to K.O. cancer
Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard – according to research published today. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy – oxidants – as an ally.
Novel enzyme inhibitor paves way for new cancer drug
Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development.
A Smarter Way to Grow Graphene
Graphene, a sheet of carbon just one atom thick, has many potential uses in the electronics industry, but producing these ideal two-dimensional carbon sheets is very difficult and, as a result, their use has been stifled so far. But scientists from Brookhaven National Laboratory may have finally found a way around the issue, devising a method to yield high-quality graphene sheets.
Artificial photosynthesis moves a step closer
Jülich scientists have made an important step on the long road to artificially mimicking photosynthesis. They were able to synthesise a stable inorganic metal oxide cluster, which enables the fast and effective oxidation of water to oxygen.
Efficient Catalysts for Making Oxygen for 'Artificial Photosynthesis'
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and the Institute for Molecular Science in Japan are trying to mimic part of the complex natural process of photosynthesis with the goal of making non-polluting fuels such as hydrogen, for example, for use in fuel cells. In the March 10, 2008, web release of the journal
Inorganic Chemistry containing a Forum on "Making Oxygen," the scientists report they were able to mimic the "water oxidation catalysis" that occurs in natural photosynthesis.
Research reveals secret to interaction between Earth's core and mantle
Leslie Hayden’s research into deep Earth interactions has led to some important findings, particularly for someone so new to the field, and the scientific world is paying attention. Hayden, a graduate student at Rensselaer Polytechnic Institute, is first author on a paper to be published in the scientific journal
Nature. The findings will be published in the Nov 29, 2007 edition of the journal.
Researchers shed light on light-emitting nanodevice
An interdisciplinary team of Cornell nanotechnology researchers has unraveled some of the fundamental physics of a material that holds promise for light-emitting, flexible semiconductors. The discovery, which involved years of perfecting a technique for building a specific type of light-emitting device, is reported in the Sept. 30 online publication of the journal Nature Materials.
New catalysts may create more, cheaper hydrogen
A new class of catalysts created at the U.S. Department of Energy's Argonne National Laboratory may help scientists and engineers overcome some of the hurdles that have inhibited the production of hydrogen for use in fuel cells.